TipRanks
Alterity Therapeutics Ltd (ATHE)
NASDAQ:ATHE
US Market
Want to see ATHE full AI Analyst Report?

Alterity Therapeutics (ATHE) Income Statement

317 Followers

Alterity Therapeutics Income Statement

Last quarter (Q4 2026), Alterity Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Alterity Therapeutics's net income was AU$-13.98M. See Alterity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 5.44MAU$ 4.02MAU$ 3.92MAU$ 5.12M
Gross Profit
AU$ -113.01KAU$ 5.31MAU$ 3.80MAU$ 3.63MAU$ 4.76M
Operating Expenses
AU$ 27.69MAU$ 19.89MAU$ 23.41MAU$ 18.24MAU$ 20.26M
Depreciation and Amortization
AU$ 113.01KAU$ 28.31KAU$ 35.34KAU$ 37.85KAU$ 54.21K
EBITDA
AU$ -27.69MAU$ -14.63MAU$ -19.57MAU$ -14.60MAU$ -17.39M
Operating Income
AU$ -27.80MAU$ -14.57MAU$ -19.60MAU$ -14.64MAU$ -15.50M
Other Income/Expenses
AU$ 1.49MAU$ 2.49MAU$ 524.33KAU$ 904.68KAU$ 2.72M
Pretax Income
AU$ -26.31MAU$ -12.08MAU$ -19.08MAU$ -13.70MAU$ -12.78M
Net Income
AU$ -22.89MAU$ -12.15MAU$ -19.12MAU$ -13.81MAU$ -12.85M
Per Share Metrics
Basic EPS
AU$ -1.32AU$ -1.14AU$ -3.12AU$ -3.42AU$ -3.18
Diluted EPS
AU$ -1.32AU$ -1.14AU$ -3.12AU$ -3.42AU$ -3.18
Weighted Average Shares Outstanding
17.54M 10.66M 6.08M 4.05M 4.01M
Weighted Average Shares Outstanding (Diluted)
17.54M 10.66M 6.08M 4.05M 4.01M
Currency in AUD

Alterity Therapeutics Earnings and Revenue History